State-Funded Stem Cell Research

New Jersey put it in the budget. California may put it on a ballot. The two states announced in recent weeks that they are looking to give stem cell research a cash infusion.A group in California is trying to get a bond initiative on the ballot in November that would provide $3 billion (US)-roughly $300 million per year for 10 years-to support stem cell research. And if the New Jersey budget proposal passes, it would provide $6.5 million in the first year, and an additional $50 million in public

Written byTheresa Tamkins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

New Jersey put it in the budget. California may put it on a ballot. The two states announced in recent weeks that they are looking to give stem cell research a cash infusion.

A group in California is trying to get a bond initiative on the ballot in November that would provide $3 billion (US)-roughly $300 million per year for 10 years-to support stem cell research. And if the New Jersey budget proposal passes, it would provide $6.5 million in the first year, and an additional $50 million in public and private funds for the next five years to support stem cell research.

"Politically speaking, [state funding of stem cell research] is kind of a punch in the eye to George W. Bush," says David Beck, president of the Coriell Institute in Camden, NJ. "Both California and New Jersey ... are saying don't play politics with science. Play politics with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies